Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations
作者： Laurent Kaiser , Cynthia Wat , Tracy Mills , Paul Mahoney , Penelope Ward
DOI: 10.1001/ARCHINTE.163.14.1667
关键词:
摘要: … placebo- or oseltamivir (75 mg twice daily)-treated adults with influenza infection. Date of hospitalization was missing for 1 oseltamivir and 2 placebo recipients. One oseltamivir-treated …
core.ac.uk
sci-hub.se 参考文章(17)
D Fleming, N L Goddard, M Nunn, C A Joseph, J M Watson, M Zambon, Influenza surveillance in England and Wales: October 1999 to May 2000. Communicable disease and public health. ,vol. 3, pp. 261- 266 ,(2000)
Scott A Harper, Keiji Fukuda, Timothy M Uyeki, Nancy J Cox, Carolyn B Bridges, None, Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report. ,vol. 55, pp. 1- 40 ,(2004)
Susan K. Bowles, Wayne Lee, Andrew E. Simor, Mary Vearncombe, Mark Loeb, Susan Tamblyn, Margaret Fearon, Yan Li, Allison McGeer, The Oseltamivir Compassionate Use P, Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. Journal of the American Geriatrics Society. ,vol. 50, pp. 608- 616 ,(2002) , 10.1046/J.1532-5415.2002.50153.X
D. M. FLEMING, M. ZAMBON, A. I. M. BARTELDS, Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands. Epidemiology and Infection. ,vol. 124, pp. 245- 253 ,(2000) , 10.1017/S0950268899003660
C. Martin, P. Mahoney, P. Ward, Oral oseltamivir reduces febrile illness in patients considered at high risk of influenza complications International Congress Series. ,vol. 1219, pp. 807- 811 ,(2001) , 10.1016/S0531-5131(01)00359-4
Ralph Gonzales, Uncomplicated Acute Bronchitis Annals of Internal Medicine. ,vol. 133, pp. 981- 991 ,(2000) , 10.7326/0003-4819-133-12-200012190-00014
John J. Treanor, Frederick G. Hayden, Peter S. Vrooman, Rick Barbarash, Robert Bettis, Dennis Riff, Sudeep Singh, Nelson Kinnersley, Penelope Ward, Roger G. Mills, for the US Oral Neuraminidase Study Group, Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza JAMA. ,vol. 283, pp. 1016- 1024 ,(2000) , 10.1001/JAMA.283.8.1016
Morteza Naghavi, Zeba Barlas, Said Siadaty, Sameh Naguib, Mohammad Madjid, Ward Casscells, Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction Circulation. ,vol. 102, pp. 3039- 3045 ,(2000) , 10.1161/01.CIR.102.25.3039
Laurent Kaiser, Oliver N. Keene, Janet M. J. Hammond, Mike Elliott, Frederick G. Hayden, Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and Adults JAMA Internal Medicine. ,vol. 160, pp. 3234- 3240 ,(2000) , 10.1001/ARCHINTE.160.21.3234
Kristin L. Nichol, J. Wuorenma, T. von Sternberg, Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens Archives of Internal Medicine. ,vol. 158, pp. 1769- 1776 ,(1998) , 10.1001/ARCHINTE.158.16.1769